论文部分内容阅读
60例2型糖尿病合并有DPN患者,均在统一调控血糖治疗方案的基础上,静脉滴注前列地尔10μg和疏血通6ml,一次/天,连续应用14天。结果:VAS评分、TCSS评分均较治疗前降低(P<0.01);TC、TG、LDL均显著改善(P<0.05);CRP显著下降(P<0.01);正中神经、腓总神经MNCV和SNCV较治疗前明显提高(P<0.01)。结论:前列地尔联合疏血通注射液治疗DPN疗效显著。
Sixty patients with type 2 diabetes mellitus (DPN) were treated with intravenous alprostadil 10μg and Shuxuetong 6ml intravenously once daily for 14 consecutive days on the basis of unified control of blood glucose treatment. Results: The scores of VAS and TCSS were significantly lower than those before treatment (P <0.01), TC, TG and LDL were significantly improved (P <0.05), and CRP was significantly decreased (P <0.01). The median nerve, peroneal nerve MNCV and SNCV Than before treatment was significantly increased (P <0.01). Conclusion: Alprostadil combined Shuxuetong injection for the treatment of DPN significant effect.